Memorial Sloan Kettering Opens Center In India Amid Rising D
Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, has launched MSKCC India, its latest expansion in Asia at a time of rising demand for healthcare service in the region. The India center located in Chennai provides remote opinions through video or written consultations to cancer patients, as well as access to Memorial Sloan Kettering oncologists, research, clinical trials and education, Memorial Sloan Kettering said.

The New York-headquartered cancer center is partnering with iCliniq, a leading global telemedicine provider based in India. MSKCC India will bring together U.S. experts, Indian doctors and scientists, patient advocacy groups and others, said Dr. Mrinal Gounder, a medical oncologist and Physician Ambassador to India and Asia at Memorial Sloan Kettering Cancer Center. “This sort of comprehensive effort is critical to providing the level of care that patients need in India and beyond, and to ultimately eradicate cancer in the 21st century globally.”

“Meeting the needs of cancer patients in India and improving their long-term health and survival rates will require close collaboration with the cancer community in India, and MSKCC India marks an important first step toward advancing such collaborations,” said Dr. Murray Brennan, the Senior Vice President of International Programs at Memorial Sloan Kettering Cancer Center.

The India center is part of a larger strategy of international outreach through collaboration and partnerships on cancer care, research and education in Asia, according to Dr. Bob Li, an oncologist who is Memorial Sloan Kettering’s Physician Ambassador to China and Asia-Pacific. Memorial Sloan Kettering’s partners in China include MORE Health, Beijing Saint Lucia Consulting and the Chinese Thoracic Oncology Group, an alliance of more than 30 cancer centers in the country.